<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00306657</url>
  </required_header>
  <id_info>
    <org_study_id>2005/057</org_study_id>
    <nct_id>NCT00306657</nct_id>
  </id_info>
  <brief_title>Normal Tension and Chronic Open Angle Glaucoma and Cerebrospinal Fluid Composition</brief_title>
  <official_title>Normal Tension and Chronic Open Angle Glaucoma, Cerebrospinal Fluid Composition in Subarachnoid Space of Affected Optic Nerves</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Aarau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Aarau</source>
  <brief_summary>
    <textblock>
      Normal tension glaucoma (NTG) and chronic open angle glaucoma (COAG) occurring progressively
      with optimal conventional or intraocular pressure reducing surgery are still unsolved
      problems in ophthalmology. The investigators would like to investigate whether or not the
      composition of cerebrospinal fluid (CSF) surrounding the optic nerve (ON) in these patients
      is pathologic under certain conditions. They therefore compare the CSF taken during optic
      nerve sheath fenestration with the CSF taken during a lumbar puncture. The investigators'
      hypothesis is that, in patients with NTG and COAG, the composition of CSF surrounding the
      affected ON plays an important role in promoting progressive visual function loss.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will recruit 30 patients with progressive visual function loss, due to Normal tension
      glaucoma (NTG) or chronic open angle glaucoma (COAG), despite optimal conventional or
      intraocular pressure reducing surgery treatment so far. We will proceed with an optic nerve
      sheath fenestration (ONSF) (according to the studies in the literature, e.g. Wax MB, Barrett
      DA, Hart WM Jr, Custer PL. Optic nerve sheath decompression for glaucomatous optic neuropathy
      with normal intraocular pressure. Arch Ophthalmol. 1993;111(9):1219-28.) and compare the
      cerebrospinal fluid (CSF) taken from the subarachnoid space (SAS) of the optic nerve (ON)
      with the CSF taken during a lumbar puncture, on the same day. Concentrations of
      neurobioactive substances will especially be studied. Visual acuity and visual field
      development before and after ONSF will be studied. Quality of life assessment will be done
      before and several times after ONSF.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2006</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual field</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life assessment</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Laboratory markers work-up</measure>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Glaucoma Open-Angle</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Optic nerve sheath fenestration</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Documented progressive visual function loss over 2 years (visual field or visual
             acuity)

          -  Intraocular pressure measured as a maximum of 25 mmHg

          -  Possibility of receiving general anaesthesia and optic nerve sheath fenestration.

        Exclusion Criteria:

          -  Secondary glaucoma

          -  Oral medication to lower intraocular pressure (carboanhydrase inhibitor)

          -  Visual acuity worse than 20/400

          -  Any other type of glaucoma (pseudoexfoliation, narrow or closed angle).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanspeter E Killer, MD, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Aarau, Department of ophthalmology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hanspeter E Killer, MD, Prof</last_name>
    <phone>+41628385021</phone>
    <email>killer@ksa.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gregor P Jaggi, MD</last_name>
    <phone>+41763261306</phone>
    <email>gregor.jaggi@gmx.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kantonsspital Aarau, Department of Ophthalmology, Switzerland</name>
      <address>
        <city>Aarau</city>
        <state>Aargau</state>
        <zip>5001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanspeter E Killer, MD, Prof</last_name>
      <phone>+41628385021</phone>
      <email>killer@ksa.ch</email>
    </contact>
    <contact_backup>
      <last_name>Gregor P Jaggi, MD</last_name>
      <phone>+41763261306</phone>
      <email>gregor.jaggi@gmx.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Hanspeter E Killer, MD Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.ksa.ch</url>
    <description>Kantonsspital Aarau, Aargau, Switzerland</description>
  </link>
  <reference>
    <citation>Wax MB, Barrett DA, Hart WM Jr, Custer PL. Optic nerve sheath decompression for glaucomatous optic neuropathy with normal intraocular pressure. Arch Ophthalmol. 1993 Sep;111(9):1219-28.</citation>
    <PMID>8363465</PMID>
  </reference>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2006</study_first_submitted>
  <study_first_submitted_qc>March 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2006</study_first_posted>
  <last_update_submitted>June 23, 2011</last_update_submitted>
  <last_update_submitted_qc>June 23, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 27, 2011</last_update_posted>
  <keyword>Glaucoma Open-Angle</keyword>
  <keyword>Normal tension glaucoma progressive</keyword>
  <keyword>chronic open angle glaucoma progressive</keyword>
  <keyword>optic nerve sheath fenestration</keyword>
  <keyword>cerebrospinal fluid</keyword>
  <keyword>Beta-Trace Protein</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

